Treating Multiple Sclerosis: A Multifaceted Approach
Treating multiple sclerosis requires a strategy that addresses two distinct challenges: slowing the underlying disease process and managing the symptoms that affect daily life. Because MS varies widely from person to person, there is no single treatment that works for everyone. Instead, care is built around the specific type of MS a person has, the frequency and severity of relapses, and the nature of the symptoms they experience.
More from this site
Keep reading the latest coverage
The goal of modern treatment is to reduce inflammation that damages myelin and nerve fibers, prevent new lesions from forming, and preserve function over time. This is achieved through a combination of medications, rehabilitation, and lifestyle adjustments that work together as part of a long-term management plan.
Disease-Modifying Therapies for MS
Disease-modifying therapies, or DMTs, are the cornerstone of treating multiple sclerosis for relapsing forms of the disease. These medications work by modulating the immune system to reduce the frequency and severity of relapses and to slow the accumulation of disability. The landscape of DMTs has expanded significantly in recent years, offering options that range from injectable therapies to oral medications and monoclonal antibodies administered intravenously.
Treatment selection depends on factors such as disease activity, the presence of lesions on MRI, a patient's lifestyle, and tolerance for risk. Some therapies require regular monitoring through blood tests or MRI scans to watch for potential side effects. The decision to start, switch, or stop a DMT is made collaboratively between a patient and their neurologist, often based on how the disease is behaving over time.
Common Categories of DMTs
- Injectable medications, such as interferons and glatiramer acetate, which have been used for decades and are often a starting point.
- Oral therapies including fingolimod, dimethyl fumarate, and teriflunomide, which offer convenience but require monitoring for specific risks.
- Infusion therapies like ocrelizumab, natalizumab, and alemtuzumab, which are often reserved for more active disease or when first-line options are insufficient.
- Newer agents that target specific immune pathways, offering the potential for greater efficacy with a tailored risk profile.
Managing Acute Relapses
When a relapse occurs, treating multiple sclerosis also involves addressing the immediate inflammation that causes new or worsening symptoms. High-dose corticosteroids, typically given intravenously for a short course, are the standard treatment to shorten the duration of an attack and speed recovery. In cases where steroids are not effective or cannot be used, plasma exchange may be considered as an alternative approach to remove harmful antibodies from the blood.
It is important to distinguish a true relapse from a pseudo-relapse, where symptoms temporarily worsen due to factors like heat, infection, or stress. Recognizing this difference helps avoid unnecessary treatment and ensures that disease-modaging therapy remains on track.
Symptom Management and Rehabilitation
Beyond modifying the disease itself, treating multiple sclerosis means actively managing the symptoms that affect quality of life. Fatigue, one of the most common and disabling symptoms, can be addressed through structured exercise programs, energy conservation techniques, and in some cases, medications like amantadine or modafinil. Spasticity and stiffness may be treated with physical therapy, stretching routines, and oral medications such as baclofen or tizanidine.
Rehabilitation plays a central role in maintaining mobility and independence. Physical therapy helps improve strength, balance, and gait, while occupational therapy focuses on adapting daily activities and the home environment. Speech-language pathology can be valuable when MS affects swallowing or communication.
Lifestyle Strategies That Support Treatment
A growing body of evidence suggests that lifestyle factors can influence the course of MS and complement medical treatment. Regular physical activity, even in modest amounts, has been associated with reduced fatigue and improved mood. A balanced diet rich in fruits, vegetables, and omega-3 fatty acids supports overall health, though no specific diet has been proven to treat MS on its own.
Vitamin D levels are often monitored and supplemented when low, as deficiency has been linked to worse outcomes in MS. Smoking cessation is strongly encouraged, as smoking accelerates disease progression. Stress management techniques, adequate sleep, and social support round out a comprehensive approach to living well with MS.
Treatment for Progressive Forms of MS
Historically, treating multiple sclerosis has been most effective for relapsing-remitting MS, while progressive forms have presented greater challenges. However, recent approvals have changed this picture. Ocrelizumab was the first DMT approved for primary progressive MS, and several other therapies are being studied for progressive disease. For secondary progressive MS that still has inflammatory activity, DMTs remain an important option.
Managing progressive MS also relies heavily on rehabilitation strategies and symptom-focused care to maintain function and comfort, since the disease process increasingly involves nerve degeneration alongside, or instead of, inflammation.
Monitoring and Long-Term Planning
Treating multiple sclerosis is an ongoing process that requires regular monitoring. Neurological exams, MRI scans, and sometimes blood tests or neuropsychological assessments help track disease activity and the effectiveness of treatment. This information guides decisions about whether to continue, adjust, or change therapies over time.
Because MS is a chronic condition, the relationship between a patient and their healthcare team is long-term. Open communication about treatment goals, side effects, and changes in symptoms ensures that care evolves alongside the disease and continues to meet the patient's needs.